<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Myanmar (01-Jan-2011-31-Dec-2012)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, Save the Children Federation, Inc.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2011-01-01" />
    <activity-date type="2" iso-date="2011-01-01" />
    <activity-date type="3" iso-date="2012-12-31" />
    <activity-date type="4" iso-date="2012-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="ca1f663f-97b9-41cc-ab7e-973ba65bedcf">
      <transaction-type code="3" />
      <transaction-date iso-date="2010-12-13" />
      <value currency="USD" value-date="2010-12-13">1310022.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="68b759b4-83be-4ad2-a146-492190176761">
      <transaction-type code="2" />
      <transaction-date iso-date="2011-01-01" />
      <value currency="USD" value-date="2011-01-01">3170663.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8eecc39-2610-49a8-a853-3f1825c5cf25">
      <transaction-type code="3" />
      <transaction-date iso-date="2011-12-16" />
      <value currency="USD" value-date="2011-12-16">1049275.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d3ae9bd-419e-487d-a14c-7353de2294d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-06-06" />
      <value currency="USD" value-date="2012-06-06">811366.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling up of TB Control in Myanmar - Myanmar (01-Jan-2013-31-Dec-2016)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar faces a major public health problem in Tuberculosis (TB).  The country is listed among the 22 high TB burden countries, among the 41 high TB and HIV burden countries and among the 27 high multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB burden countries. In 2007, an estimated 124,416 TB cases were notified in all forms, corresponding to a case notification rate of 265 cases per 100,000 population.  The program is implemented through a Dual Financing Track scheme and focuses on TB and high risk patients.  The proposal for this grant builds on the National TB Strategic Plan 2011 to 2015, and coordinated with both the National HIV/AIDS and Malaria proposals. The program aims to reduce the burden of TB by 2015 in line with the Millennium Development Goals (MDG) and Stop TB components of the new Stop TB Strategy.  The activities under current grant will enhance the quality and expand services to all TB patients, sustain and further improve case detection and treatment success rate.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the burden of TB by 2015 in line with the MDGs and STOP TB Partnership targets. Objectives: Addressing TB/HIV, MDR-TB and other challenges such as TB care for high risk groups in border areas and infection control; Advocacy, Communication, Social Mobilization (ASCM) and community based DOTS in hard-to-reach areas by partner agencies; Engaging all health care providers through Public-Private Mix DOTS, Public-Public Mix DOTS and introducing the International Standards of TB Care (ISTC) in other sectors; Pursuing high quality DOTS: Enhancing the quality and expanding services to all TB patients, to sustain and further imporve case detection and treatment success rates.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2013-01-01" />
    <activity-date type="2" iso-date="2013-01-01" />
    <activity-date type="3" iso-date="2016-12-31" />
    <activity-date type="4" iso-date="2016-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="08d75012-30ce-4d5e-befc-b8c49555568f">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-01-15" />
      <value currency="USD" value-date="2013-01-15">1531834.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5bed2c59-602c-4da5-bbbe-39e055c0d665">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-08-13" />
      <value currency="USD" value-date="2013-08-13">2684675.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0892e3ca-19e2-4af4-a4db-9c1e06e889a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-01-16" />
      <value currency="USD" value-date="2014-01-16">4398819.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85d1e933-e0ea-44e4-ad24-7c397e08f716">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-06-03" />
      <value currency="USD" value-date="2014-06-03">-182310.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8be85f5b-fc0d-4466-9e90-861ba8220277">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-06-03" />
      <value currency="USD" value-date="2014-06-03">2977402.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="18be4802-a5b5-4443-8cd8-ef658105601b">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-06-04" />
      <value currency="USD" value-date="2014-06-04">2029684.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e419caea-a4aa-46d1-b01b-a4442e04e8f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-02-16" />
      <value currency="USD" value-date="2015-02-16">947718.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3191131f-fa3e-4e51-a6ce-07cf61aed8c9">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-05-26" />
      <value currency="USD" value-date="2015-05-26">6978259.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f8125e3f-6a0b-4692-ba9e-f63b92db77cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-05-27" />
      <value currency="USD" value-date="2015-05-27">2190034.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2e085cd-97ca-44ce-9aab-d0d1353f8cad">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-06" />
      <value currency="USD" value-date="2015-08-06">457857.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="881c33c5-1730-4da5-bff3-116154c25362">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-11-03" />
      <value currency="USD" value-date="2015-11-03">3017906.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0b4d89fe-ed13-4926-bc44-767e4e95efd5">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-10" />
      <value currency="USD" value-date="2016-02-10">285164.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="66ce77ba-2c80-4778-95fb-b176bf61c1db">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-19" />
      <value currency="USD" value-date="2016-05-19">-1027298.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="70e00122-e193-4c4b-a956-74a9e86f68a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-19" />
      <value currency="USD" value-date="2016-05-19">5768141.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2adfaa2f-743e-4e76-bc3f-c863fb7f1d87">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-20" />
      <value currency="USD" value-date="2016-05-20">838045.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9b8bbf2f-c4a5-4cc8-9b5d-d0d9b2a67d75">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-08-25" />
      <value currency="USD" value-date="2016-08-25">3295307.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="edf8a743-8fd5-4c76-8364-5161698b7c9a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-11-30" />
      <value currency="USD" value-date="2016-11-30">-1634789.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Current grant. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="16">
          <comment>
            <narrative>Numerator: 23610; Denominator: 147984.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="15.6">
            <comment>
              <narrative>Numerator: 24000; Denominator: 153714.</narrative>
            </comment>
          </target>
          <actual value="15.5">
            <comment>
              <narrative>Numerator: 22083; Denominator: 142170.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="14.1">
            <comment>
              <narrative>Numerator: 10800; Denominator: 76788.</narrative>
            </comment>
          </target>
          <actual value="14.1">
            <comment>
              <narrative>Numerator: 9360; Denominator: 66593.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 24000; Denominator: 159974.</narrative>
            </comment>
          </target>
          <actual value="14.1">
            <comment>
              <narrative>Numerator: 20004; Denominator: 141944.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 12300; Denominator: 81770.</narrative>
            </comment>
          </target>
          <actual value="13.1">
            <comment>
              <narrative>Numerator: 8991; Denominator: 68623.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="11.9">
            <comment>
              <narrative>Numerator: 20188; Denominator: 170354.</narrative>
            </comment>
          </target>
          <actual value="13.4">
            <comment>
              <narrative>Numerator: 18886; Denominator: 140699.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="12.3">
            <comment>
              <narrative>Numerator: 10123; Denominator: 82111.</narrative>
            </comment>
          </target>
          <actual value="13.03">
            <comment>
              <narrative>Numerator: 8443; Denominator: 64799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="13.4">
            <comment>
              <narrative>Numerator: 22890; Denominator: 171065.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Current grant. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 5267.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8000; Denominator: 153174; Percentage: 5.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8574; Denominator: 142170; Percentage: 6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4510; Denominator: 76788; Percentage: 5.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4810; Denominator: 66593; Percentage: 7.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9900; Denominator: 159974; Percentage: 6.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10402; Denominator: 141944; Percentage: 7.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5220; Denominator: 81770; Percentage: 6.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5112; Denominator: 68623; Percentage: 7.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11488; Denominator: 170354; Percentage: 6.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11157; Denominator: 140699; Percentage: 7.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5980; Denominator: 82111; Percentage: 7.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4994; Denominator: 64799; Percentage: 7.71%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13000; Denominator: 171065; Percentage: 7.6%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Myanmar (01-Jan-2017-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, Save the Children Federation, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). Objectives: Objective 1: accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB; Objective 2: fully integrate TB prevention and care in Universal Health Coverage; Objective 3: enhance the prevention of TB, particularly for high-risk populations.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2017-01-01" />
    <activity-date type="2" iso-date="2017-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="a23b177d-0757-48a5-8fdb-25822da96e7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-02-16" />
      <value currency="USD" value-date="2017-02-16">7094504.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6bd5ef52-b9f3-45ab-aa11-c1930136a99b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-17" />
      <value currency="USD" value-date="2017-02-17">2075587.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c86cfdba-e3ff-43b6-9633-ba3ac027702a">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-11" />
      <value currency="USD" value-date="2017-05-11">1715986.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1ef835b-41e4-4282-905f-2934f2dfdb23">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">1652147.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7feb3008-be8d-417d-b924-6a1a07d73566">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-14" />
      <value currency="USD" value-date="2017-11-14">1071158.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d121dbf3-57af-4c4c-b427-b8304da2f1a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">-579626.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="4675" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="4040" />
          <actual value="3561" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="8417" />
          <actual value="8418" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="18886" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="8180" />
          <actual value="6874" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="18060" />
          <actual value="14248" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="69.2">
          <comment>
            <narrative>Numerator: 204; Denominator: 295.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="74.8">
            <comment>
              <narrative>Numerator: 86; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 128; Denominator: 161.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="74.8">
            <comment>
              <narrative>Numerator: 86; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="76.2">
            <comment>
              <narrative>Numerator: 131; Denominator: 172.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="95.5">
          <comment>
            <narrative>Numerator: 50367; Denominator: 52715.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 49568; Denominator: 49568.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 50965; Denominator: 51809.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 47777; Denominator: 47777.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 50420; Denominator: 51264.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="51.7">
          <comment>
            <narrative>Numerator: 11157; Denominator: 21567.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 5985; Denominator: 8550.</narrative>
            </comment>
          </target>
          <actual value="64.8">
            <comment>
              <narrative>Numerator: 4320; Denominator: 6664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 13300; Denominator: 19000.</narrative>
            </comment>
          </target>
          <actual value="65.8">
            <comment>
              <narrative>Numerator: 9619; Denominator: 14608.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis Prevention and Control for Vulnerable Populations - Myanmar (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, Save the Children Federation, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). Objectives: Objective 1: accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB; Objective 2: fully integrate TB prevention and care in Universal Health Coverage; Objective 3: enhance the prevention of TB, particularly for high-risk populations.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="68.4">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="31.6">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="2.22">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="32.83">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd90b50-0924-481f-b5a1-22b7305b5dbb" percentage="2.53">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="2c00622f-0877-4553-993e-389582dbbfd1" percentage="2.95">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="3.79">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="a9a15642-9d30-4ac6-85fe-0d687727c2d2" percentage="24.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="0.53">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="12.68">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="6.08">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="9.58">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="2.47">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">5007770.14</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">5430692.59</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">6322019.94</value>
    </budget>
    <capital-spend percentage="2" />
    <transaction ref="560ae6ae-6a0b-409e-8c1b-1604b1569e50">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-01-08" />
      <value currency="USD" value-date="2018-01-08">6124618.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="faa7284c-c03e-4f16-af25-42502e5491a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-16" />
      <value currency="USD" value-date="2018-01-16">1349747.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24a6fddb-3e52-4594-9813-f6989c6e063a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">737676.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b368a41b-7a47-4333-91c8-28c607ef6363">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-09" />
      <value currency="USD" value-date="2018-08-09">988752.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5f027a5a-8c47-42a1-a983-c123a5927e3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-30" />
      <value currency="USD" value-date="2018-10-30">863181.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb540dbd-368b-4d6e-8319-097e0ad6cb59">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-10" />
      <value currency="USD" value-date="2019-01-10">1732006.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ccb980ee-cfd8-4f2c-a708-66d7ca89b863">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">453256.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9ccd3a6a-ceef-44d6-9150-2800010a0e42">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-15" />
      <value currency="USD" value-date="2019-05-15">6299959.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41c8f540-76a1-494f-9b1c-941d094a1dfe">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-16" />
      <value currency="USD" value-date="2019-05-16">2237592.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b5c49815-32d2-4bfb-9f7a-615891dbaf65">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-26" />
      <value currency="USD" value-date="2019-09-26">1224609.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="566b0371-4b0a-480b-9ed7-17d06a6dd9e3">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-09" />
      <value currency="USD" value-date="2020-01-09">1031222.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="602a1f5d-d405-403b-b786-1355b3c37e99">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">1789923.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b188d78-2d05-4795-8747-73e673bab708">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-25" />
      <value currency="USD" value-date="2020-06-25">-16613.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2dfd4bbe-a58a-4359-969f-7aa95db7becc">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-25" />
      <value currency="USD" value-date="2020-06-25">3447057.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ab3cf28-ad44-4f3b-96f2-64eb780644a3">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-27" />
      <value currency="USD" value-date="2020-06-27">1710330.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a843f01b-2115-43c7-8072-5ecc159ff71c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">1350524.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="786d3099-b195-400d-a88b-79c743fbb466">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-26" />
      <value currency="USD" value-date="2022-07-26">-386203.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MMR-T-SCFP04-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">5007770.16</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP04, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP04-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">5431584.29</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP04, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP04-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">5180492.00</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP04, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP04-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">176823.96</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP04, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 5052.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4437.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3621.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4439.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4941; Percentage: 111%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6007.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3633; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6015.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5544.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6088.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3975.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6099.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3591.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 18970.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6319.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6420; Percentage: 77%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6990.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6052; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6990.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6003.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7001.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4288.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7001.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3238.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="76.81">
          <comment>
            <narrative>Numerator: 202; Denominator: 263.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="80.1">
            <comment>
              <narrative>Numerator: 133; Denominator: 166.</narrative>
            </comment>
          </target>
          <actual value="81.5">
            <comment>
              <narrative>Numerator: 123; Denominator: 151.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="80.1">
            <comment>
              <narrative>Numerator: 266; Denominator: 332.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 255; Denominator: 300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90.4">
            <comment>
              <narrative>Numerator: 169; Denominator: 187.</narrative>
            </comment>
          </target>
          <actual value="83">
            <comment>
              <narrative>Numerator: 78; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90.13">
            <comment>
              <narrative>Numerator: 338; Denominator: 375.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 202; Denominator: 232.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90.31">
            <comment>
              <narrative>Numerator: 177; Denominator: 196.</narrative>
            </comment>
          </target>
          <actual value="84.4">
            <comment>
              <narrative>Numerator: 54; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.05">
            <comment>
              <narrative>Numerator: 353; Denominator: 392.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 91; Denominator: 103.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="99.2">
          <comment>
            <narrative>Numerator: 52038; Denominator: 52458.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 41978; Denominator: 41978.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 37585; Denominator: 38108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 39571; Denominator: 39571.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 38791; Denominator: 39676.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 30958; Denominator: 30958.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 35304; Denominator: 35871.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 29573; Denominator: 29573.</narrative>
            </comment>
          </target>
          <actual value="99.9">
            <comment>
              <narrative>Numerator: 31427; Denominator: 31470.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 28418; Denominator: 28418.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 27729; Denominator: 27740.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 26811; Denominator: 26811.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 25307; Denominator: 25310.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="16.49">
          <comment>
            <narrative>Numerator: 291; Denominator: 1765.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="50.1">
            <comment>
              <narrative>Numerator: 250; Denominator: 499.</narrative>
            </comment>
          </target>
          <actual value="45.7">
            <comment>
              <narrative>Numerator: 544; Denominator: 1190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="50.1">
            <comment>
              <narrative>Numerator: 500; Denominator: 998.</narrative>
            </comment>
          </target>
          <actual value="55.2">
            <comment>
              <narrative>Numerator: 1405; Denominator: 2543.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 502; Denominator: 836.</narrative>
            </comment>
          </target>
          <actual value="53">
            <comment>
              <narrative>Numerator: 499; Denominator: 941.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="60.05">
            <comment>
              <narrative>Numerator: 744; Denominator: 1239.</narrative>
            </comment>
          </target>
          <actual value="68.5">
            <comment>
              <narrative>Numerator: 1239; Denominator: 1809.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="65.03">
            <comment>
              <narrative>Numerator: 584; Denominator: 898.</narrative>
            </comment>
          </target>
          <actual value="64">
            <comment>
              <narrative>Numerator: 365; Denominator: 570.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="65.05">
            <comment>
              <narrative>Numerator: 780; Denominator: 1199.</narrative>
            </comment>
          </target>
          <actual value="73.3">
            <comment>
              <narrative>Numerator: 807; Denominator: 1101.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="57.27">
          <comment>
            <narrative>Numerator: 12469; Denominator: 21771.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8140; Denominator: 9044.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 5294; Denominator: 7049.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8141; Denominator: 9046.</narrative>
            </comment>
          </target>
          <actual value="77.8">
            <comment>
              <narrative>Numerator: 6115; Denominator: 7864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8221; Denominator: 9134.</narrative>
            </comment>
          </target>
          <actual value="85.1">
            <comment>
              <narrative>Numerator: 5550; Denominator: 6520.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8221; Denominator: 9134.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 6595; Denominator: 7585.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8291; Denominator: 9212.</narrative>
            </comment>
          </target>
          <actual value="86.5">
            <comment>
              <narrative>Numerator: 4662; Denominator: 5387.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8291; Denominator: 9212.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 3657; Denominator: 4021.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-5</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis Prevention and Control for Vulnerable Populations - Myanmar (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, Save the Children Federation, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. Objectives: Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP05" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="57.55">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="42.45">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.02">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="40.43">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.82">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.42">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="23a802a3-2312-4589-bbe9-62a7cf2c91d2" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0.32">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="22.44">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="13.9">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="8.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="4.93">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="1.79">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="1.93">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="2.36">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="31f7c6af-8b6f-4289-90f3-c6f20f232eb7" percentage="1.76">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">4525822.03</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">5816390.77</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">6438888.06</value>
    </budget>
    <capital-spend percentage="1.36" />
    <transaction ref="cd66a18d-31c3-4ec5-becc-10d42c0cea6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-08" />
      <value currency="USD" value-date="2021-01-08">8220234.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ffda5fb9-04eb-4d97-b2c8-2f4480f21001">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-13" />
      <value currency="USD" value-date="2021-01-13">1477384.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="98bc6871-60ed-4df8-b99a-8349e9f7d932">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">558039.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9bf8c933-4c85-4754-b5b0-d5db11c1d0fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">595924.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3decdcb-d0c3-4093-9533-c02a8949236f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1282814.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fe63e8c8-712a-4e8b-8cc4-4aea36e3d623">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">1390130.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06b38771-c8e1-4eaf-b74a-ea53b806963f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-14" />
      <value currency="USD" value-date="2022-04-14">1113239.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a8a6b800-d68e-4349-88d7-8c1b4e52e7c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">1365321.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9dd6edb4-be39-4bb9-8797-097529df2ea3">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-27" />
      <value currency="USD" value-date="2022-09-27">4990329.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c15caee7-6ec9-4cbd-a16c-3841d7dcfff7">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-27" />
      <value currency="USD" value-date="2022-09-27">-437383.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aabb40f0-eea1-4271-9fa3-cd821d505763">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">1401800.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="44b82b13-60d1-4150-ba72-ec2a11690fbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-19" />
      <value currency="USD" value-date="2022-12-19">1500000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6f2fb93-5e8e-40a9-9290-fa00234e8e1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-30" />
      <value currency="USD" value-date="2023-03-30">1200000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05b87844-1b60-49be-aa5d-f29ebe79e4e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-27" />
      <value currency="USD" value-date="2023-06-27">888529.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9fc62295-7332-419f-82b0-70d0258eb39a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-14" />
      <value currency="USD" value-date="2023-07-14">3395007.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3717ffae-0be6-4087-a7fd-a40bfd340478">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">411471.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40f670e7-71c9-4346-bd00-8421f4e8202c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-28" />
      <value currency="USD" value-date="2023-09-28">2200000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d5ffec5c-b37b-4bbd-b6a1-f08a150d9fb7">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-23" />
      <value currency="USD" value-date="2025-06-23">-783536.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8a59d4e-6d25-4d4f-8d99-72415f35c621">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-461899.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a970d2d6-4d20-4c94-bea2-47280f3e1db9">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">461899.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from MMR-T-SCFP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MMR-T-SCFP05-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">4525822.03</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP05, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP05-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">5015921.20</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP05, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP05-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">5848842.07</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP05, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP05-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">277575.00</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP05, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MMR/2020/TB_HIV/en/MMR-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - TB/HIV - Myanmar - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR677-MMR-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="9177" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="10877" />
          <actual value="6538" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="5438" />
          <actual value="3124" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5439" />
          <actual value="3414" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10768" />
          <actual value="10496" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5383" />
          <actual value="5035" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5385" />
          <actual value="5461" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5195" />
          <actual value="5442" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="10390" />
          <actual value="10680" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5195" />
          <actual value="5238" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="12055" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="6647" />
          <actual value="6463" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="13295" />
          <actual value="11416" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="6648" />
          <actual value="4953" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="6580" />
          <actual value="7469" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="13161" />
          <actual value="15018" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="6581" />
          <actual value="7549" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="6348" />
          <actual value="6953" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="12697" />
          <actual value="13733" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6349" />
          <actual value="6780" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="87.07">
          <comment>
            <narrative>Numerator: 202; Denominator: 232.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90.4">
            <comment>
              <narrative>Numerator: 66; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="78.1">
            <comment>
              <narrative>Numerator: 50; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="89.58">
            <comment>
              <narrative>Numerator: 43; Denominator: 48.</narrative>
            </comment>
          </target>
          <actual value="83.9">
            <comment>
              <narrative>Numerator: 26; Denominator: 31.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 23; Denominator: 25.</narrative>
            </comment>
          </target>
          <actual value="72.7">
            <comment>
              <narrative>Numerator: 24; Denominator: 33.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="91.4">
            <comment>
              <narrative>Numerator: 32; Denominator: 35.</narrative>
            </comment>
          </target>
          <actual value="85.7">
            <comment>
              <narrative>Numerator: 42; Denominator: 49.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 18; Denominator: 20.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 23; Denominator: 27.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="93.33">
            <comment>
              <narrative>Numerator: 14; Denominator: 15.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 19; Denominator: 22.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="83.1">
            <comment>
              <narrative>Numerator: 453; Denominator: 545.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="87.78">
          <comment>
            <narrative>Numerator: 12145; Denominator: 13835.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 7338; Denominator: 7724.</narrative>
            </comment>
          </target>
          <actual value="84.7">
            <comment>
              <narrative>Numerator: 6747; Denominator: 7970.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 14676; Denominator: 15448.</narrative>
            </comment>
          </target>
          <actual value="83.7">
            <comment>
              <narrative>Numerator: 12040; Denominator: 14379.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 7338; Denominator: 7724.</narrative>
            </comment>
          </target>
          <actual value="82.6">
            <comment>
              <narrative>Numerator: 5293; Denominator: 6409.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 7079; Denominator: 7451.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 8278; Denominator: 9509.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 14160; Denominator: 14904.</narrative>
            </comment>
          </target>
          <actual value="87.5">
            <comment>
              <narrative>Numerator: 17128; Denominator: 19565.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 7081; Denominator: 7453.</narrative>
            </comment>
          </target>
          <actual value="88">
            <comment>
              <narrative>Numerator: 8850; Denominator: 10056.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="96.01">
            <comment>
              <narrative>Numerator: 6765; Denominator: 7046.</narrative>
            </comment>
          </target>
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 8696; Denominator: 9589.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 13530; Denominator: 14093.</narrative>
            </comment>
          </target>
          <actual value="91.9">
            <comment>
              <narrative>Numerator: 17034; Denominator: 18538.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 6765; Denominator: 7047.</narrative>
            </comment>
          </target>
          <actual value="93.2">
            <comment>
              <narrative>Numerator: 8338; Denominator: 8949.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-SCF-6</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis Prevention and Control for Vulnerable Populations - Myanmar (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, Save the Children Federation, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. Objectives: Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response; Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Save the Children Federation, Inc.</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-SCFP06" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Allan Nfamba</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>allan.nfamba@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="57.2">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="42.8">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="36.79">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="1.49">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="3.28">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="4.23">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.95">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="35.54">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="8.72">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="1.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="3d6a34f1-64c6-4b78-96a6-3ac438f510cf" percentage="3.21">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Key populations</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="1.1">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="2.11">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">5045148.98</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">4828702.60</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">3576768.07</value>
    </budget>
    <capital-spend percentage="2.47" />
    <transaction ref="6e2d7f37-807b-4dbe-8d82-1f5d9c592f27">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-18" />
      <value currency="USD" value-date="2024-01-18">6958984.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b1790158-6952-47e6-bd86-d111e1d2a00c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-23" />
      <value currency="USD" value-date="2024-01-23">1278719.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="17ee9dbb-53ab-411a-ae29-33078b2f0779">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-18" />
      <value currency="USD" value-date="2024-04-18">1160000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b8e685e9-ff39-41f9-aa66-2f331722cba2">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">904000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3b96f639-3b68-49a3-bd8b-c00cdde5ac2c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="48939d81-b68a-4025-aa7a-224be0c3d17a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-17" />
      <value currency="USD" value-date="2024-12-17">1019700.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0b86cf42-c5a4-47cc-ad4d-2a2e6118f542">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">1248460.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9ff76a5b-69a5-4f67-ae4c-3ed6216f750e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">461899.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7cafb994-f6a4-4f63-9e41-60377ec54653">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">461899.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9966f2c1-cea9-4fa5-9d82-c6bff6dbc529">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-18" />
      <value currency="USD" value-date="2025-07-18">-348105.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c6b6b427-4abc-428f-9b96-0430ccb3d6a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-18" />
      <value currency="USD" value-date="2025-07-18">1780000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34e40cc1-80a8-4a44-a03b-3f102bfb7e24">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">1200000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="38f315db-9aaa-44eb-b0aa-e7d0c5fde3cc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">1186000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc5da73d-b3f9-4254-9ea6-7e31208d6bf5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">-580000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="361e4ccc-da9e-4d82-8f1d-098a9f843be1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">1186000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d227fe7b-99b8-4400-afab-b9e1a3ddf90a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-10" />
      <value currency="USD" value-date="2026-01-10">2195600.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="79eff273-3305-4360-b00e-eaec5eebfb56">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">470000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="051668d6-8262-43f3-aecd-fd18bad0646d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">1490000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="02039569-c1e7-4b07-979c-5b49d8f104d9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-26" />
      <value currency="USD" value-date="2026-09-26">-235600.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8576c87b-49f7-44d4-b6bd-117d3c88c103">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-26" />
      <value currency="USD" value-date="2026-09-26">473000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-SCFP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b1f520e-90d0-42e8-a8c2-4504ca9eab2b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">473000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-SCFP06 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="MMR-T-SCFP06-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">4327282.13</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP06, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-SCFP06-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2976614.95</value>
      <description>
        <narrative>Expenditure reported by Save the Children Federation, Inc. for MMR-T-SCFP06, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Save the Children Federation, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-SCF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MMR/2023/TB_HIV/en/MMR-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Myanmar - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1437-MMR-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - Co-Financing (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD11,317,958 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.2 (1)(a) and 5.2(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase domestic expenditure   on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the Commitment Letter to be submitted in form and substance satisfactory to the Global Fund, by 30 June 2024,: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing commitment letter, including with respect to national program procurement for anti-TB drugs and TB diagnostics; and (c) provide to the Global Fund, by no later than each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: (i) the approved annual budget for TB including with respect to the procurement of anti-TB drugs, and TB diagnostics for the upcoming year; (ii) the total expenditure for TB in the previous fiscal year, including procurement of anti-TB drugs, and TB diagnostics; and (iii) the co-financing and programmatic progress report for the Implementation Period of the Grant.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6 hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6 hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Principal Recipient shall ensure that: (1) it and any Sub-recipient or Supplier: (a) complies with applicable Economic Sanctions Law, including by, as applicable, not entering into any agreement or transaction, or engaging in activities with or for the benefit of any sanctioned individual or entity, or involving any sanctioned country or territory, except as permitted under Economic Sanctions Law applicable to the Principal Recipient, any Grant Sub-recipient or Supplier, the Use of Grant Funds or implementation of Program Activities; or (b) engage in, transact or otherwise facilitate any export, transfer or transmission of goods, services, software, technical data or technology in violation of any applicable regulations, laws or legally binding measures. Economic Sanctions Law referred to in this sub-section are defined as follows: “Economic Sanctions Law” means any economic or financial sanctions administered by the Office of Foreign Assets Control of the United States Department of the Treasury (“OFAC”), the United States State Department, any other agency of the United States government, the United Nations, the United Kingdom, the European Union or any member state thereof, and/or Switzerland; (2) it and any Sub-recipients or Suppliers have reasonable controls in place to ensure compliance with sub-section (1) above (including, without limitation, verifying that counterparties are not designated by applicable Economic Sanctions Law before requesting quotations from them and having robust contractual provisions in place with Sub-recipients and Suppliers regarding compliance with applicable Economic Sanctions Law); and (3) the Global Fund is promptly notified in writing of any act or omission materially inconsistent with the requirements of this sub-section.</narrative>
      </condition>
      <condition type="1">
        <narrative>5 - With respect to Grant Funds disbursed by the Principal Recipient to the International Organization for Migration (IOM) pursuant to the terms of this Grant Agreement, the Principal Recipient shall, unless otherwise agreed in writing by the Global Fund, provide to the Global Fund: (a) quarterly reports of total disbursements made to IOM; and (b) expenditure reports of such disbursements on a semi-annual basis in accordance with Section 6.2 of the Global Fund Grant Regulations (as amended from time to time).</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="84.25">
          <comment>
            <narrative>Numerator: 12883; Denominator: 15291.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 12863; Denominator: 14293.</narrative>
            </comment>
          </target>
          <actual value="84.48">
            <comment>
              <narrative>Numerator: 16039; Denominator: 18985.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="89.99">
            <comment>
              <narrative>Numerator: 6431; Denominator: 7146.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6432; Denominator: 7147.</narrative>
            </comment>
          </target>
          <actual value="84.39">
            <comment>
              <narrative>Numerator: 7722; Denominator: 9150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 5851; Denominator: 6501.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 11834; Denominator: 13150.</narrative>
            </comment>
          </target>
          <actual value="86.45">
            <comment>
              <narrative>Numerator: 13040; Denominator: 15084.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="89.98">
            <comment>
              <narrative>Numerator: 5983; Denominator: 6649.</narrative>
            </comment>
          </target>
          <actual value="87.14">
            <comment>
              <narrative>Numerator: 7058; Denominator: 8100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90.01">
            <comment>
              <narrative>Numerator: 6479; Denominator: 7198.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6480; Denominator: 7200.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TB Other 1 Number of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>TB Other 1 Number of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="15018" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="7488" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="15124" />
          <actual value="12937" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="7636" />
          <actual value="6560" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="16421" />
          <actual value="8348" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="8210" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8211" />
          <actual value="2506" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="8641" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="8642" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TB Other 2 Number of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>TB Other 2 Number of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="10496" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="4765" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="9531" />
          <actual value="5561" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="4766" />
          <actual value="3869" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="5417" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="10835" />
          <actual value="5814" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="5418" />
          <actual value="2068" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="5918" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="5918" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 42; Denominator: 49; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 42; Denominator: 49; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 42; Denominator: 49; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8; Denominator: 8; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8; Denominator: 8; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 41; Percentage: 82.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 41; Percentage: 82.93%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 887; Denominator: 1181; Percentage: 75.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 677; Denominator: 843; Percentage: 80.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 441; Denominator: 587; Percentage: 75.13%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 446; Denominator: 594; Percentage: 75.08%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 396; Percentage: 77.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 660; Denominator: 820; Percentage: 80.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 17; Denominator: 20; Percentage: 85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 141; Denominator: 180; Percentage: 78.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 536; Denominator: 663; Percentage: 80.84%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 517; Denominator: 672; Percentage: 76.93%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1034; Denominator: 1344; Percentage: 76.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 356; Denominator: 432; Percentage: 82.41%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 517; Denominator: 672; Percentage: 76.93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 69; Denominator: 83; Percentage: 83.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 350; Denominator: 425; Percentage: 82.35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 6; Denominator: 6; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 85; Denominator: 113; Percentage: 75.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 271; Denominator: 319; Percentage: 84.95%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 570; Denominator: 712; Percentage: 80.06%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 570; Denominator: 712; Percentage: 80.06%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 17128; Denominator: 19565; Percentage: 87.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 15355; Denominator: 16678; Percentage: 92.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 15355; Denominator: 16678; Percentage: 92.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 1025; Denominator: 1443; Percentage: 71.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 1025; Denominator: 1443; Percentage: 71.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 748; Denominator: 1444; Percentage: 51.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 748; Denominator: 1444; Percentage: 51.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 6236; Denominator: 7209; Percentage: 86.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 6236; Denominator: 7209; Percentage: 86.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 10892; Denominator: 12356; Percentage: 88.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 10892; Denominator: 12356; Percentage: 88.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 1055; Denominator: 17128; Percentage: 6.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 1055; Denominator: 17128; Percentage: 6.16%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11837; Denominator: 13150; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14481; Denominator: 15055; Percentage: 96.19%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5852; Denominator: 6501; Percentage: 90.02%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5985; Denominator: 6649; Percentage: 90.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7807; Denominator: 8085; Percentage: 96.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12573.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 1158.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 750.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5656.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 8825.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 843.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13389; Denominator: 14398; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9669; Denominator: 10017; Percentage: 96.53%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6694; Denominator: 7198; Percentage: 93%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6695; Denominator: 7200; Percentage: 92.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2451; Denominator: 2584; Percentage: 94.85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 8578.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 701.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 390.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3653.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 6016.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 432.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7084; Denominator: 7458; Percentage: 95.01%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7085; Denominator: 7458; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>